Enfortumab vedotin plus pembrolizumab in the treatment of locally advanced or metastatic bladder cancer of variant histology: A phase II study

被引：0
|
作者：
Nazha, Bassel
Brown, Jacqueline T.
Liu, Yuan
Kissick, Haydn
Carthon, Bradley Curtis
Kucuk, Omer
Harik, Lara R.
Narayan, Vikram M.
Joshi, Shreyas S.
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA
[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA
[3] Emory Univ, Dept Urol, Sch Med, Atlanta, GA USA
[4] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA USA
[5] Emory Univ, Dept Urol, Atlanta, GA USA
[6] Emory Univ, Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4615
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter
    Papamichael, D
    Gallagher, CJ
    Oliver, RTD
    Johnson, PW
    Waxman, J
    BRITISH JOURNAL OF CANCER, 1997, 75 (04) : 606 - 607
  • [32] Enfortumab vedotin 202: Phase 2 study of enfortumab vedotin for previously treated advanced solid tumors, including breast cancer
    Ono, Makiko
    Bruce, Justine Yang
    Feinstein, Trevor
    Muro, Kei
    Derleth, Christina
    Gorla, Seema
    Wu, Chunzhang
    Novik, Yelena
    CANCER RESEARCH, 2022, 82 (04)
  • [33] Study EV-103: Update on durability results and long term outcome of enfortumab vedotin plus pembrolizumab in first line locally advanced or metastatic urothelial carcinoma (la/mUC).
    Friedlander, Terence W.
    Milowsky, Matthew I.
    Bilen, Mehmet Asim
    Srinivas, Sandy
    Mckay, Rana R.
    Flaig, Thomas W.
    Hoimes, Christopher J.
    Balar, Arjun Vasant
    Henry, Elizabeth
    Petrylak, Daniel P.
    Sasse, Carolyn
    Kataria, Ritesh S.
    Yu, Yao
    Carret, Anne-Sophie
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Perioperative pembrolizumab or pembrolizumab plus Enfortumab Vedotin (EV) for muscle-invasive bladder cancer (MIBC): Phase 3 KEYNOTE-905/EV-303
    Necchi, A.
    Bedke, J.
    Galsky, M. D.
    Shore, N. D.
    Xylinas, E.
    Jia, C.
    Dubrovsky, L.
    Homet, Moreno B.
    Witjes, A. J.
    EUROPEAN UROLOGY, 2023, 83 : S751 - S751
  • [35] Phase II study of bavituximab plus docetaxel in patients with locally advanced or metastatic breast cancer
    Tabagari, D.
    Nemsadze, G.
    Jincharadze, M.
    Janjalia, M.
    Shan, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [37] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [38] Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China
    Li, Siming
    Shi, Yanxia
    Dong, Haiying
    Guo, Hongqian
    Xie, Yu
    Sun, Zhongquan
    Zhang, Xiaoping
    Kim, Eric
    Zhang, Jun
    Li, Yue
    Xu, Chenming
    Kadeerbai, Haishan
    Lee, Sue
    Gorla, Seema
    Guo, Jun
    Sheng, Xinan
    CANCER MEDICINE, 2024, 13 (21):
  • [39] Real-world use, dose intensity, and adherence to enfortumab vedotin in locally advanced or metastatic urothelial cancer
    Mamtani, Ronac
    Tsingas, Konstantinos
    Parikh, Ravi B.
    Elsouda, Dina
    Mucha, Lisa
    Fuldeore, Rupali
    Hubbard, Rebecca A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (06) : e1 - e4
  • [40] A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer
    Duska, Linda
    Romano, Kara
    Holman, Laura
    Crane, Erin
    Wethington, Stephanie
    Fields, Emma
    Randall, Leslie
    Schwarz, Julie
    Petroni, Gina
    Bullock, Timothy
    Scalici, Jennifer
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S5 - S5
12345